News

Anne Wojcicki lands 23andMe again. What $305 million deal means for company, customers, shareholders
Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne ...
US judge won't block 23andMe bankruptcy sale to co-founder
A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...
Colorado AG: Consumers who want to delete 23andMe accounts should ‘do so now’
Colorado Attorney General Phil Weiser is sounding the alarm for Coloradans on deleting data shared with 23andMe, following ...
23andMe, Inc.: TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
TTAM Research Institute ("TTAM"), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that ...
23andMe users have until today to file a claim in the DNA company's bankruptcy case. Here's how to do it.
For 23andMe customers who believe they have a claim against the company’s services, but it isn’t cybersecurity-related, they ...
Peninsula biotech Jasper Therapeutics to lay off half its staff as cash runs low
This Peninsula biotech is laying off half its staff as it narrows the focus of its main drug.
23andMe users have until July 14 to file a claim in the DNA company's bankruptcy case. Here's how to do it.
Customers of the genetic testing company 23andMe have until July 14 to file a claim as part of a restructuring in its ...
23andMe data breach: Deadline looms for customers seeking compensation
To qualify for a cybersecurity-related claim, one must be a 23andMe customer between May 1, 2023, and Oct. 1, 2023; have received a notice that their personal information was compromised in the 2023 ...
FDA panel to revisit menopausal hormone therapy
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
23andMe Sale to Proceed as California Continues Appeal (Correct)
A federal district judge allowed 23andMe Holding Co.'s genetic material asset sale to proceed in the coming days, despite the state of California’s objections.
23andMe bankruptcy sale can proceed, Missouri federal judge says
A federal judge in St. Louis ruled that the sale of the direct-to-consumer genetic testing company 23andMe and its assets, despite concerns from the state of California over customer privacy.